A/P 25/30 (Oseni 25 mg / 30 mg)

Generic Name: alogliptin/pioglitazone

Pill imprint A/P 25/30 has been identified as Oseni 25 mg / 30 mg.

Oseni is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 25 mg / 30 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for A/P 25/30

Oseni
Generic Name:
alogliptin/pioglitazone
Imprint:
A/P 25/30
Strength:
25 mg / 30 mg
Color:
Peach
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC):
64764-0253
Inactive Ingredients:
mannitol
hydroxypropyl cellulose (type l)
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
hypromellose 2910 (6 mPa.s)
titanium dioxide
polyethylene glycol 8000
magnesium silicate
lactose monohydrate
ferric oxide red
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)